SBI Securities’s PAVmed PAVM Stock Holding History

SBI Securities’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$398	Hold	67	–	–	﹤0.01%	3117
2026 Q1	$680	Buy	67 +63	+1,575%	+$596	﹤0.01%	2788
2025 Q4	$24	Hold	4	–	–	﹤0.01%	3740
2025 Q3	$47	Hold	4	–	–	﹤0.01%	3739
2025 Q2	$65	Hold	4	–	–	﹤0.01%	3663
2025 Q1	$78	Hold	4	–	–	﹤0.01%	3527
2024 Q4	$68	Buy	+4	New	+$118	﹤0.01%	3560

Other funds holding PAVM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

SBI Securities's PAVM Position: Q2 2026 in Review

SBI Securities held its PAVmed (PAVM) position steady in Q2 2026 at 67 shares worth $398. The position accounts for ﹤0.01% of the portfolio, ranked #3117.

SBI Securities first reported a position in PAVM in Q4 2024 and has held it in 7 quarters since. The position peaked at $680 in Q1 2026. 3 funds tracked by Wall St. Rank hold PAVM as of Q2 2026.

SBI Securities held 67 shares of PAVmed worth $398 as of Q2 2026.
SBI Securities left its PAVmed share count unchanged in Q2 2026.
PAVmed made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3117 holding.
SBI Securities first reported a position in PAVmed in Q4 2024 and has held it in 7 quarters since.
SBI Securities's PAVmed position peaked at $680 in Q1 2026.
3 funds tracked by Wall St. Rank held PAVmed as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.